MODEL VERDICT
BioHarvest Sciences Inc. Common Stock (BHST)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 13 industry peers | $2.86 | -40.0% | 4% | B | Data |
| Price / Sales 13 industry peers | $2.64 | -44.7% | 3% | B | Model Driven |
| Weighted Output Blended model output | $3.02 | -36.8% | 100% | 34 | SIGNIFICANTLY OVERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
Based on our peer multiples analysis with 4 valuation metrics, the model estimates BHST's fair value at $3.02 vs the current price of $4.77, implying -36.8% downside potential. Model verdict: Significantly Overvalued. Confidence: 34/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $3.02 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $1.67 (P10) to $3.86 (P90), with a median of $2.75.
BHST's current P/E of -6.0x compares to the industry median of 27.0x (9 peers in the group). This represents a -122.1% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
1 analysts cover BHST with a consensus rating of Buy. The consensus price target is $13.50 (range: $12.00 — $15.00), implying +183.0% upside from the current price. Grade breakdown: Strong Buy (0), Buy (1), Hold (0), Sell (0), Strong Sell (0).
The model confidence score is 34/100, based on: data completeness (6), peer quality (25), historical depth (5), earnings stability (5), and model agreement (3). Cyclicality penalty: --10 points. The model shows weak agreement across inputs — interpret with caution.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for BHST.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.